Finance

Lists
SGO:CVE
Sonoro Gold Corp
CA$0,16
0,00%
(0,00) 1D
13 āšž.āšˆ., 16 āŧ‚āšĄāš‡ 0 āš™āšēāš—āšĩ 00 āš§āšīāš™āšēāš—āšĩ GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SGO...
Open
CA$0,16
High
CA$0,16
Low
CA$0,16
Mkt. cap
70,47 āšĨāŧ‰āšēāš™
Avg. vol.
116,24Â āšžāšąāš™
Volume
199,28Â āšžāšąāš™
52-wk high
CA$0,34
52-wk low
CA$0,14
EPS
CA$-0,03
Beta
0,03
Shares outstanding
431,94 āšĨāŧ‰āšēāš™
Open
CA$0,16
High
CA$0,16
Low
CA$0,16
Mkt. cap
70,47 āšĨāŧ‰āšēāš™
Avg. vol.
116,24Â āšžāšąāš™
Volume
199,28Â āšžāšąāš™
52-wk high
CA$0,34
52-wk low
CA$0,14
EPS
CA$-0,03
Beta
0,03
Shares outstanding
431,94 āšĨāŧ‰āšēāš™
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
S&P 500 Snapshot: Stocks Up 2.5% To Log Best Week Since August
A News
A News
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
US stocks close mixed as tech losses weigh on Nasdaq, Europe mostly up
TradingView
TradingView
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Innovative Immunology Biotech Windward Bio Lists on Nasdaq
CNBC
CNBC
·
10 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Is a bottom in for the Nasdaq-100? Charts to watch
About Sonoro Gold Corp
CEO-
Employees-
Founded30 āšž.āšˆ. 1944
HeadquartersWest Vancouver, āššāšĢāšīāš—āšīāšŠ āŧ‚āš„āšĨāšģāŧ€āššāš, āŧāš„āš™āšēāš”āšē
SectorMaterials
Industry-
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
544,56Â āšžāšąāš™
-3,05 āšĨāŧ‰āšēāš™
569,57Â āšžāšąāš™
845,59Â āšžāšąāš™
Operating expense
5,24 āšĨāŧ‰āšēāš™
-2,42 āšĨāŧ‰āšēāš™
1,39 āšĨāŧ‰āšēāš™
1,85 āšĨāŧ‰āšēāš™
Total operating expenses
5,24 āšĨāŧ‰āšēāš™
-2,42 āšĨāŧ‰āšēāš™
1,39 āšĨāŧ‰āšēāš™
1,85 āšĨāŧ‰āšēāš™
Operating income
-5,24 āšĨāŧ‰āšēāš™
2,42 āšĨāŧ‰āšēāš™
-1,39 āšĨāŧ‰āšēāš™
-1,85 āšĨāŧ‰āšēāš™
Other non operating income
-19,70Â āšžāšąāš™
-11,46Â āšžāšąāš™
-25,95Â āšžāšąāš™
-38,72Â āšžāšąāš™
EBT including unusual items
-5,81 āšĨāŧ‰āšēāš™
2,21 āšĨāŧ‰āšēāš™
-1,48 āšĨāŧ‰āšēāš™
-2,37 āšĨāŧ‰āšēāš™
EBT excluding unusual items
-5,81 āšĨāŧ‰āšēāš™
2,21 āšĨāŧ‰āšēāš™
-1,48 āšĨāŧ‰āšēāš™
-2,37 āšĨāŧ‰āšēāš™
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
13,82Â āšžāšąāš™
75,91Â āšžāšąāš™
-
Net income
-5,81 āšĨāŧ‰āšēāš™
2,21 āšĨāŧ‰āšēāš™
-1,48 āšĨāŧ‰āšēāš™
-2,37 āšĨāŧ‰āšēāš™
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-436,66Â āšžāšąāš™
-153,48Â āšžāšąāš™
-102,64Â āšžāšąāš™
-54,07Â āšžāšąāš™
Net interest expenses
-436,66Â āšžāšąāš™
-153,48Â āšžāšąāš™
-102,64Â āšžāšąāš™
-54,07Â āšžāšąāš™
Depreciation and amortization charges
8,96Â āšžāšąāš™
34,39Â āšžāšąāš™
11,55Â āšžāšąāš™
23,09Â āšžāšąāš™
EBITDA
-5,23 āšĨāŧ‰āšēāš™
2,45 āšĨāŧ‰āšēāš™
-1,38 āšĨāŧ‰āšēāš™
-1,83 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google